Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease

Journal of Cardiovascular Medicine

Volumn 11, Issue 1, 2010, Pages 20-25

  Rizzello, Vittoria ^c   Liuzzo, Giovanna ^a   Trabetti, Elisabetta ^b   Di Giannuario, Giovanna ^a   Brugaletta, Salvatore ^a   Santamaria, Matteo ^a   Piro, Maddalena ^a   Boccanelli, Alessandro ^c   Pignatti, Pier Franco ^b   Biasucci, Luigi M ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; CD14; Inflammation; Polymorphism

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; FEMALE; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; ANTIGENS, CD14; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 74249101493     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328330e9fb     Document Type: Article

References (26)

1. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331:417-424.
2. Maseri A, Biasucci LM, Liuzzo G. Pathogenic mechanisms in unstable angina. Heart 1999; 82 (Suppl):I2-4.
3. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88:358-363.
4. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12.
5. Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A, et al. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: evidence for a direct proinflammatory effect of azide and lipopolysaccharide- free C-reactive protein on human monocytes via nuclear factor kappa-B activation. J Am Coll Cardiol 2007; 49: 185-194.
6. Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 2001; 103:3062-3068.
7. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98:2370-2376.
8. Liuzzo G, Biasucci LM, Gallimore JR, Caligiuri G, Buffon A, Rebuzzi AG, et al. Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 1999; 34:1696-1703.
9. Liuzzo G, Angiolillo DJ, Buffon A, Rizzello V, Colizzi C, Ginnetti F, et al. Enhanced response of blood monocytes to in vitro lipopolysaccharidechallenge in patients with recurrent unstable angina. Circulation 2001; 103:2236-2241.
10. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1:509-516.
11. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activate the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000; 164:13-17.
12. Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 1995; 125:662-671.
13. Loppnow H, Stelter F, Schonbeck U, Schlüter C, Ernst M, Schütt C, et al. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 1995; 63:1020-1026.
14. Hubacek JA, Rothe G, Pítha J, Skodová Z, Stane? k V, Poledne R, et al. C(-260)¡T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99:3218-3220.
15. Baldini M, Lohman IC, Halonen M, Ericksson RP, Holt PG, Martinez FD. A Polymorphism-in the 50 flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Resp Cell Mol Biol 1999; 20:976-983.
16. Angiolillo DJ, Biasucci LM, Liuzzo G, Crea F. Inflammation in acute coronary syndromes: mechanisms and clinical implications. Rev Esp Cardiol 2004; 57:433-446.
17. Biasucci LM, Liuzzo G, Ciervo A, Petrucca A, Piro M, Angiolillo DJ, et al. Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 2003; 107:3015-3017.
18. Kondo T, Ohno M, Shimokata K, Iino S, Inden Y, Murohara T, et al. CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis. Heart 2003; 89:931-932.
19. Bernardo E, Angiolillo DJ, Ramirez C, Cavallari U, Trabetti E, Sabaté M, et al. Influence of the CD14 C(-260)T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease. Am J Cardiol 2006; 98:1182-1184.
20. Liuzzo G, Biasucci LM, Trotta G, Brugaletta S, Pinnelli M, Di Gianuario G, et al. Unusual CD4pCD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50:1450-1458.
21. Arroyo-Espliguero R, El-Sharnouby K, Vazquez-Rey E, Kalidas K, Jeffery S, Kasky JC. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Card 2005; 98:307-312.
22. Porsch-Ozcurumez M, Hucke J, Westphal S, Hubacek JA, Schmitz G, Luley C. A posthoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease. Physiol Res 2007; 56:727-733.
23. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19:932-938.
24. Koenig W, Khuseyinova N, Hoffmann MM,März W, Fröhlich M, Hoffmeister A, et al. CD14 C(-260)¡T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 2002; 40:34-42.
25. Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker P. A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 2001; 154:699-702.
26. Morange PE, Saut E, Alessi MC, Frere C, Hawe E, Yudkin JS, et al., HIFMECH Study Group. Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study 2005. Atherosclerosis 2005; 179:317-323.